VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

What is MDR? Understanding Medical Device Regulation Compliance

Common imputation methods and when to use them

What is MDR? Understanding Medical Device Regulation Compliance

Common imputation methods and when to use them

What is MDR? Understanding Medical Device Regulation Compliance

Common imputation methods and when to use them

CRO
Market Entry
Research

Published on Jan 6, 2026

3 min read time

What is MDR?
MDR stands for Medical Device Regulation - a comprehensive regulatory framework that governs the development, manufacturing, and distribution of medical devices within the European Union. The regulation was officially published in 2017 and became fully applicable on May 26, 2021, marking a significant shift in how medical devices are regulated and approved for market access.
Why MDR Matters
The implementation of MDR was driven by several critical factors:

  • Enhanced Patient Safety: The regulation introduces stricter requirements for clinical evidence and post-market surveillance

  • Improved Transparency: Greater requirements for device traceability and information sharing

  • Harmonized Standards: Creates consistent regulatory requirements across all EU member states

  • Future-Proofing: Addresses emerging technologies and novel device types
    Key Changes Under MDR

  1. Classification System Updates
    MDR introduces more stringent classification rules, potentially moving devices to higher risk categories that require more rigorous clinical evidence and Notified Body involvement.

  2. Enhanced Clinical Evidence Requirements

  • More comprehensive clinical data requirements

  • Mandatory clinical investigations for high-risk devices

  • Stricter requirements for clinical evaluation reports (CERs)

  1. Post-Market Surveillance (PMS)

  • Enhanced post-market surveillance requirements

  • Mandatory post-market clinical follow-up (PMCF) for certain devices

  • More detailed safety reporting obligations

  1. Unique Device Identification (UDI)

  • Implementation of UDI system for device traceability

  • Enhanced labeling requirements

  • Improved device identification throughout the supply chain
    MDR Compliance Challenges
    Many medical device companies face significant challenges in achieving MDR compliance:
    Technical Documentation

  • More comprehensive technical documentation requirements

  • Enhanced risk management documentation

  • Stricter quality management system requirements
    Clinical Evidence

  • Difficulty in gathering sufficient clinical data for legacy devices

  • Challenges in conducting new clinical studies

  • Complex requirements for clinical evaluation reports
    Notified Body Capacity

  • Limited availability of Notified Bodies

  • Extended review timelines

  • Increased costs for conformity assessment
    The Impact on Different Stakeholders
    Medical Device Manufacturers

  • Increased regulatory burden and costs

  • Need for enhanced quality management systems

  • Requirement for more comprehensive clinical data
    Healthcare Providers

  • Improved device safety and performance information

  • Better traceability of devices

  • Enhanced post-market surveillance data
    Patients

  • Greater confidence in device safety

  • Improved access to device information

  • Enhanced protection through stricter regulations
    How Consulting Services Can Help
    Navigating MDR compliance requires specialized expertise and strategic planning. Professional consulting services can provide:
    Strategic Planning

  • Gap analysis of current compliance status

  • Development of MDR transition roadmaps

  • Risk assessment and mitigation strategies
    Technical Documentation Support

  • Preparation of enhanced technical documentation

  • Clinical evaluation report development

  • Risk management documentation assistance
    Quality Management System Enhancement

  • QMS gap analysis and improvement

  • Process optimization for MDR compliance

  • Staff training and competency development
    Clinical Evidence Strategy

  • Clinical data gap analysis

  • PMCF study design and implementation

  • Clinical evaluation planning and execution
    Notified Body Interaction

  • Preparation for Notified Body audits

  • Documentation review and optimization

  • Communication strategy with regulatory bodies
    FDA Perspective on MDR
    The U.S. Food and Drug Administration (FDA) recognizes the importance of international harmonization in medical device regulation. While the FDA operates under different regulatory frameworks, there are areas of alignment between FDA requirements and MDR:

  • Both emphasize the importance of clinical evidence

  • Risk-based classification systems

  • Post-market surveillance requirements

  • Quality management system requirements
    The FDA has published guidance documents that acknowledge the value of international standards and the importance of global regulatory harmonization for medical device safety and effectiveness.
    Conclusion
    MDR represents a fundamental shift in medical device regulation that requires careful planning and strategic implementation. The regulation's emphasis on enhanced safety, transparency, and clinical evidence creates both challenges and opportunities for medical device companies.
    Successfully navigating MDR compliance requires:

  • Comprehensive understanding of regulatory requirements

  • Strategic planning and resource allocation

  • Expertise in clinical evidence development

  • Robust quality management systems

  • Effective stakeholder communication

This blog post provides general information about MDR requirements. For specific compliance guidance tailored to your organization, please contact our consulting team for personalized support.

Subscribe updates

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Terms of Use and Privacy Policy

Subscribe updates

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Terms of Use and Privacy Policy

Subscribe updates

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Terms of Use and Privacy Policy

Subscribe updates

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Terms of Use and Privacy Policy

Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.